Hocevar Christopher J 4
4 · CIGNA CORP · Filed Nov 29, 2017
Insider Transaction Report
Form 4
Hocevar Christopher J
Pres. Strat Segmts & Solutions
Transactions
- Exercise/Conversion
Common Stock, $.25 Par Value
2017-11-27$120.89/sh+6,389$772,398→ 12,363 total - Exercise/Conversion
Common Stock, $.25 Par Value
2017-11-27$78.03/sh+4,775$372,617→ 17,138 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2017-11-27−6,389→ 3,195 totalExercise: $120.89From: 2016-02-25Exp: 2025-02-25→ Common Stock, $.25 Par Value (6,389 underlying) - Sale
Common Stock, $.25 Par Value
2017-11-27$200.32/sh−8,387$1,680,094→ 8,751 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2017-11-27−4,775→ 0 totalExercise: $78.03From: 2015-02-26Exp: 2024-02-26→ Common Stock, $.25 Par Value (4,775 underlying)
Holdings
- 931.722(indirect: By 401(k))
Common Stock, $.25 Par Value
Footnotes (4)
- [F1]Represents the weighted average price of the shares sold. The prices actually received ranged from $200.26 to $200.475 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- [F2]Represents shares acquired through ongoing participation in Cigna's 401(k) Plan.
- [F3]This option vests in three equal annual installments. The first installment became exercisable on February 25, 2016, the second installment became exercisable on February 25, 2017, and the last installment becomes exercisable on February 25, 2018.
- [F4]This option was granted on February 26, 2014. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.